CD19+CD11c+ (IgD-CD27-) double negative 2 B cells emerged as autoreactive B cells that are activated in extrafollicular pathways (11) and are increased in patients with rheumatoid arthritis and other rheumatic diseases (12). Here, CD19 is linked to rheumatoid arthritis.